FBL18 Antibodies

Santa Cruz Biotechnology offers a broad range of FBL18 Antibodies for various research applications. FBL18 Antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBL18, also known as Fibrillarin, is a nucleolar protein that plays a critical role in the biogenesis of ribosomes and the processing of pre-rRNA. The protein is essential for the assembly of the nucleolar structure and is involved in the modification of rRNA, which is vital for protein synthesis in cells. Given its importance in cellular function and proliferation, FBL18 has emerged as a significant target for studies related to cancer and other diseases. Researchers can utilize FBL18 monoclonal antibodies to investigate cellular mechanisms and pathways involved in disease progression. Understanding FBL18's role in ribosome biogenesis can provide valuable insights into potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of fundamental biological processes.